Modi-Mundipharma Private Limited - Due diligence report

A 360° intelligence report on Modi-Mundipharma Private Limited: trust score, financial health, credit view, compliance, directors, growth an…

1990-10-31 New Delhi, Delhi Active Unlisted Active Compliant
Share
View plans
MP Modi-Mundipharma Private Limited
Full Due-Diligence Report + Documents
  • Unlock all financial figures & 5-year trends
  • Full trust, health & credit-risk scores
  • Director details, charges & MCA documents
₹700 ₹349 50% off New user
Or enjoy up to 50% off with credits View credit packages
Company Credits – Starter
  • One credit unlocks this full due-diligence report
  • Use across any company’s report, anytime
  • Credits valid for 12 months
× ₹700 ₹279 = ₹2,790 60% off
Choose your own credit amount View credit packages

Modi-Mundipharma Private Limited — 360° Intelligence Report

Generated from MCA filings & public records
80/100
Trust Score
Low Risk

Modi-Mundipharma Private Limited is assessed as Low Risk with a Trust Score of 80/100. Modi-Mundipharma Private Limited is an active private limited indian non-government company incorporated in 1990, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a moderate compliance risk and low financial risk profile.

Report generated on 27 Jun 2026 from the latest processed filings. Modi-Mundipharma Private Limited snapshot & full profile →

Financial Health › Strong
Overall Assessment CautionWeakNeutralGoodStrong Strong
Compliance › Good

Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.

02

Score Card

Higher is safer · rule-based & explainable
Trust ScoreLow Risk
80/100
Overall counterparty trust - the headline number of this report.
Compliance ScoreModerate
60/100
Statutory standing - status, filings, auditor, MSME and litigation.
Financial Health ScoreLow Risk
80/100
Profitability, leverage and liquidity from filed statements.
Credit Risk ScoreCaution Indicated
45/100
Debt capacity, gearing and security cover for lenders.
Director Stability ScoreLow Risk
95/100
Board strength, DIN status, churn and network.
Growth ScoreModerate
60/100
Revenue, profit, asset and hiring momentum.
Distress ScoreLow Risk
90/100
Early-warning signals - higher means fewer warnings.
03

Financial Intelligence Dashboard

Consolidated · 5 filed year(s)

Unlock the full 5-year financial dashboard with charts and year-wise figures.

Get full access

Scores and observations on this page are already computed from the real filings - only the underlying figures are locked.

04

Credit & Compliance Intelligence

Why the scores are what they are
Credit Risk Score: 45/100 Caution Indicated
  • Liabilities ≈ 38% EBITDA - stretched.
  • Open charges exceed net worth - secured lenders rank ahead.
  • Profitable - internal accruals available.
  • Externally credit-rated (A2).

Charges position: 4 open (251.75 cr) · 6 satisfied (198.98 cr).

Banking relationships (from registered charges)
LenderChargesAmount
Others4 48.0 cr
Hdfc Bank Limited6 48.0 cr
Compliance Score: 60/100 Moderate
  • Company status is Active as per MCA.
  • Balance sheet slightly behind (Mar 2024).
  • Litigation present in 3 court forum(s).
  • Delayed payments to MSME suppliers disclosed (1 disclosure(s)).
  • 20 active GST registration(s).
Legal cases on record (3)
05

Director Intelligence

Stability score: 95/100
NameDIN / PANDesignationAppointedTenureDIN status
ABHISHEK MODI 01234567 Director 01/04/2018 6 yrs Approved
KUMKUM MODI 01234567 Director 01/04/2018 6 yrs Approved
UMESH KUMAR MODI 01234567 Director 01/04/2018 6 yrs Approved
MEGHNA MODI 01234567 Director 01/04/2018 6 yrs Approved
JAYESH MODI 01234567 Director 01/04/2018 6 yrs Approved
BRYAN GEORGE LEA 01234567 Director 01/04/2018 6 yrs Approved
Sonam Chuni 01234567 Director 01/04/2018 6 yrs Approved
Vijay Kumar Modi 01234567 Director 01/04/2018 6 yrs Approved
  • 8 directors on the board.
  • No disqualified or deactivated DINs.
  • Stable board - no exits in 3 years.
  • Average tenure above 5 years.
Director & KMP remuneration (FY 2023)
NameDesignationTotal remuneration
A K SharmaManaging Director2.4 cr
R MehtaWhole-time Director1.6 cr
S IyerCFO95.0 L

Remuneration is disclosed in the latest annual return. Unlock full report

06

Ownership & Group Intelligence

As per FY 2023 annual return
Promoter holding
64.27%
Public / other holding
35.73%
Equity shares
12,45,67,890
Equity paid-up
124.5 cr
Promoters on record
4
Ultimate holding entity
-
Subsidiaries
3
Group entities
3
Capital events
-

Promoters hold a dominant controlling stake - exact percentages are part of the full report.

Group entityRelationship% held
Beauty Products Lanka Private Limited Subsidiary Company 74.00%
Modi-mundipharma Beauty Products Private Limited Subsidiary Company 74.00%
Modi-mundipharma Healthcare Private Limited Subsidiary Company 74.00%
Bangladesh Beauty Products Private Limited Subsidiary Company 74.00%
Mundipharma (bangladesh) Private Limited Subsidiary Company 74.00%
Mundipharma Trading Bangladesh Private Limited Subsidiary Company 74.00%
Win-medicare Private Limited Subsidiary Company 74.00%

Full shareholding pattern, group structure & capital events →

07

Risk Intelligence Center

Growth 60 · Distress 90
Growth signals & trust indicators
Steady revenue growth: +1.42 over 4 year(s).
Operating for 35+ years.
Active GST registration(s).
Distress signals & risk flags
4 open charge(s) registered - assets are encumbered.
MSME payment delays disclosed - latest outstanding 25.95 Lakh.
3 court case(s) on record - see the legal section for details.
08

Stakeholder Verdicts

Vendor · Banker · Investor
Vendor due diligence75/100
Favourable indicators
Suitability as a supplier / customer counterparty.
  • Check the compliance flags before onboarding.
  • No distress signals on file.
  • Financial filings available for verification.
Banker assessment59/100
Mixed indicators - deeper appraisal suggested
Indicative lending comfort for banks, NBFCs and trade credit.
  • Debt capacity assessed from filed statements.
  • 4 open charge(s) of 251.75 cr already registered.
  • Compliance gaps should be priced into terms.
Investor view72/100
Positive growth indicators
Growth quality and scalability through an investor lens.
  • 1 growth signal(s) detected.
  • Margin and return trends computable from filings.
  • Management team looks stable.
09

MCA Filings & Events Timeline

Latest 15 events
12 Aug 2025
Director appointed
Vijay Kumar Modi (Additional Director)
31 Dec 2024
Last AGM held
Annual general meeting
31 Mar 2024
Latest balance sheet
Filed with ROC
12 Jul 2023
Director appointed
Sonam Chuni (Company Secretary)
01 Nov 2022
Charge satisfied
Others
14 Apr 2022
Charge created
Others - 5.00 cr
09 Feb 2021
Charge created
Hdfc Bank Limited - 10.00 cr
29 Dec 2020
Director ceased
JAGAN NATH KHURANA
31 Dec 2019
Director ceased
STUART DAVID BAKER
14 May 2019
Director ceased
SANJAY KUMAR GARG
29 Sep 2018
Director ceased
BRYAN GEORGE LEA
20 Sep 2018
Director ceased
ANURAG SETH
19 Sep 2018
Charge satisfied
Others
04 Jun 2018
Director appointed
BRYAN GEORGE LEA (Director)
20 Sep 2017
Charge satisfied
Hdfc Bank Limited
10

Key Observations

Auto-generated from the data above
Revenue grew 2.1x over the last 4 financial year(s).
Net profit margin moved from 24% to 0.86.
Debt-to-equity stands at 61% - leverage worth monitoring.
Net worth is positive.
8 active director(s) / partner(s); board looks stable and experienced.
20 active GST registration(s) indicate ongoing business operations.
Operates a group structure with 3 subsidiary(ies) - assess on a consolidated basis.
Carries an external credit rating of A2 from Crisil.
Promoters hold a dominant controlling stake as per the FY 2023 annual return.
Director / KMP remuneration is disclosed in the latest annual return - exact figures available in the full report.
11

Peers & Related Companies

Full peer comparison →
CompanyCINLocation
Lama Rice Private Limited U15490DL2009PTC209399 New Delhi, Delhi, India
Ariston U31900PN2016FTC165930 Pune, Maharashtra, India
Citymall U51909HR2020PTC086109 Basai Road, Haryana, India
Hexa International Private Limited U17100GJ1999PTC036701 Ahmadabad City, Gujarat, India
Aryan Wellness Private Limited U51909HR2017PTC071447 Gurugram, Haryana, India
K C Garments Private Limited U18101DL2005PTC139844 New Delhi, Delhi, India
Luker U31909KL2015PTC038352 Kochi, Kerala, India
Exim Trade Service Private Limited U70109WB1993PTC058073 Kolkata, West Bengal, India
12

Who Uses This Report

CA · CS · Banker · Investor · Vendor
Chartered Accountants (CA)

Verify Modi-Mundipharma Private Limited before audits and certifications: compliance score 60/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.

Company Secretaries (CS)

Track statutory health of Modi-Mundipharma Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.

Bankers & NBFCs

Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 45/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.

Investors & Analysts

Investor view: Positive growth indicators. Growth score 60/100, margin trends, ownership structure and peer set for Modi-Mundipharma Private Limited - screening before a deeper diligence.

Vendors & Procurement Teams

Vendor verdict: Favourable indicators. Trust score 80/100, distress signals and MSME payment-delay disclosures - know whether Modi-Mundipharma Private Limited pays its suppliers before you extend credit terms.

Lawyers & Compliance Teams

Litigation footprint (3 case(s) on record), regulatory flags, charge documents trail and director networks for Modi-Mundipharma Private Limited - groundwork for KYC, onboarding and disputes.

13

Frequently Asked Questions

Is Modi-Mundipharma Private Limited an active company?

Modi-Mundipharma Private Limited has MCA status “Active” with a compliance score of 60/100 (Moderate).

Is Modi-Mundipharma Private Limited financially healthy?

Modi-Mundipharma Private Limited has a Financial Health Score of 80/100 (Low Risk) based on its filed financial statements.

Should I do business with Modi-Mundipharma Private Limited?

Its overall Trust Score is 80/100 (Low Risk). Vendor verdict: Favourable indicators. Review the risk flags in the Risk Intelligence Center before deciding.

Who controls Modi-Mundipharma Private Limited?

Promoters hold a dominant controlling stake - exact percentages are in the full report. 8 active director(s) are on record.

Does Modi-Mundipharma Private Limited have loans or charges against its assets?

4 open charge(s) are registered against its assets, and 6 earlier charge(s) stand satisfied.

Is Modi-Mundipharma Private Limited up to date with its ROC filings?

Balance sheet slightly behind (Mar 2024). Overall compliance score: 60/100 (Moderate).

Is it risky to lend to Modi-Mundipharma Private Limited?

Its Credit Risk Score is 45/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.

Disclaimer: This report is generated automatically from MCA filings and public records as available in our system at the time of the last update. Scores, bands and verdicts are rule-based derived indicators of the underlying data - they are opinions generated by an algorithm, not statements of fact about the company, and are not credit ratings (within the meaning of SEBI regulations), audits, or investment, legal or financial advice. Verify from official sources and consult a qualified professional before any business, lending or investment decision. If you represent this company and believe any information is inaccurate or outdated, report it here and we will review promptly.